-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2023.
- Barinthus Biotherapeutics plc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.25M, a 10.3% decline year-over-year.
- Barinthus Biotherapeutics plc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $5.82M, a 22.4% decline year-over-year.
- Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2023 was $7.39M, a 51.1% increase from 2022.
- Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2022 was $4.89M.
- Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2021 was -$5.92M, a 368% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)